Twinbeech Capital LP Xenon Pharmaceuticals Inc. Transaction History

Twinbeech Capital LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$36.25 - $43.75 $338,248 - $408,231	-9,331 Reduced 9.52%	88,711 $3.46 Million
Q1 2024 May 15, 2024	BUY	$42.66 - $50.04 $4.18 Million - $4.91 Million	98,042 New	98,042 $4.22 Million
Q4 2022 Feb 14, 2023	BUY	$33.06 - $39.43 $1.75 Million - $2.09 Million	52,967 Added 108.65%	101,717 $4.01 Million
Q3 2022 Nov 14, 2022	BUY	$30.79 - $39.82 $1.16 Million - $1.5 Million	37,727 Added 342.26%	48,750 $1.76 Million
Q2 2022 Aug 15, 2022	SELL	$25.44 - $35.16 $418,360 - $578,206	-16,445 Reduced 59.87%	11,023 $335,000
Q1 2022 May 16, 2022	BUY	$25.09 - $33.13 $516,603 - $682,146	20,590 Added 299.36%	27,468 $840,000
Q4 2021 Feb 14, 2022	BUY	$15.6 - $35.4 $107,296 - $243,481	6,878 New	6,878 $215,000

212

70.2M

88.3K

28.8K

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.39B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.